PlainPharmaWatch

CMS Open Payments · Program Year 2024

NX Development Corp.

NX Development Corp. reported $158,481.00 across General Payments, Research, and Ownership to 0 physicians and teaching hospitals across 9 transactions.

$158.5K
All-tracks total
9
Transactions
0
Recipients
−$37.3K
General Payments vs PY2022

NX Development Corp. reported $158,481.00 across all CMS Open Payments tracks (General + Research + Ownership) to 0 physicians and teaching hospitals in Program Year 2024 - ranking #1071 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total), averaging $0.00 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer nx-development-corp NX Development Corp.

$158.5K · #1071/1,925 · 0.0% industry · PY2024

  • TOT $158.5K
  • RANK #1071
  • SHARE 0.0%
  • TXN 9
  • RCP 0
  • CAT 0
  • GEN n/a
  • ΔGEN −$37.3K
  • PY 2024

Nearest volume peer: Surgical Planning Associates, Inc. ($158.3K)

Outset Medical Inc$160.7KMicro-tech Endoscopy USA, In…$159.3KNX Development Corp. (this)$158.5KSurgical Planning Associates…$158.3KUS Implant Solutions, LLC$157.1K
All-tracks payment totals near NX Development Corp. (CMS Open Payments PY2024)

NX Development Corp. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2022 to PY2023

NX Development Corp.'s CMS-reported General Payments decreased by $37.3K (−83.0%) from PY2022 to PY2023.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: NX DEVELOPMENT CORP.PY2023: NX DEVELOPMENT CORP.PY2024: NX Development Corp.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2022 vs PY2023

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2022$44.9KPY2023$7.7K
PY2022
$44,931.17
PY2023
$7,650.00

What the Data Shows for NX Development Corp.

$158,481.00: that is what NX Development Corp. reported in payments to 0 physicians and teaching hospitals during Program Year 2024, spread across 9 transactions ($17.6K per transaction, $0.00 per recipient). The company sits at rank #1071 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 0-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). Payments are distributed across multiple categories without a dominant single type.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with NX Development Corp..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download NX Development Corp.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.